2,467
Views
2
CrossRef citations to date
0
Altmetric
HPV – Research Paper

Long-term effect of mobile phone-based education and influencing factors of willingness to receive HPV vaccination among female freshmen in Shanxi Province, China

, , , , , , , , & ORCID Icon show all
Article: 2051990 | Received 27 Dec 2021, Accepted 08 Mar 2022, Published online: 21 Apr 2022

References

  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–9. doi:10.3322/caac.21660.
  • Arbyn M, Weiderpass E, Bruni L, de Sanjose S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-6.
  • Organizational WH. Cervical cancer. 2021.
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.29210.
  • Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41(10):1037–48. doi:10.1002/cac2.12197.
  • Herzog TJ. New approaches for the management of cervical cancer. Gynecol Oncol. 2003;90(3):S22–7. doi:10.1016/S0090-8258(03)00466-9.
  • Organization WH. Immunization coverage. 2021.
  • Xi Z, Shiyu Y, Liying S, Xiangxian F, Mingyu S, Xiaoyou S, Xiaoyu F. The utility of mobile phone-based intervention in promoting awareness and willingness to uptake human papillomavirus vaccine among female college students. Mod Preventive Med. 2021;48:888–92+934.
  • Organization WH. Existence of national HPV vaccination programme. 2021.
  • Zhu FC, Hu SY, Hong Y, Hu YM, Zhang X, Zhang YJ, Pan Q-J, Zhang W-H, Zhao F-H, Zhang C-F, et al. Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: end-of-study results from a phase II/III, randomised, controlled trial. Cancer Med. 2019;8(14):6195–211. doi:10.1002/cam4.2399.
  • Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. a Cochrane review of randomized trials. Expert Rev Vaccines. 2018;17(12):1085–91. doi:10.1080/14760584.2018.1548282.
  • Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, et al. Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial. Lancet. 2017;390(10108):2143–59. doi:10.1016/S0140-6736(17)31821-4.
  • Garland SM, Cheung TH, McNeill S, Petersen LK, Romaguera J, Vazquez-Narvaez J, Bautista O, Shields C, Vuocolo S, Luxembourg A, et al. Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine. Vaccine. 2015;33(48):6855–64. doi:10.1016/j.vaccine.2015.08.059.
  • Ma Y, Wang C, Liu F, Lian G, Li S, He Q, Li T. Human papillomavirus vaccination coverage and knowledge, perceptions and influencing factors among university students in Guangzhou, China. Hum Vaccin Immunother. 2021;17(10):3603–12. doi:10.1080/21645515.2021.1927411.
  • Xiaoxiao Z, Jinjing S, Xuan Z, Yanyang Z, Wenzhou Y. Awareness and coverage of human papilomavirus vaccine among female university students in 2019. Chin J Vaccines Immunization. 2021;27:458–61+67.
  • Jiechen L, Linlin W, Qingrui B, Jia R, Huiyong S, Zhuoying H. Surveillance for coverage of human papillomavirus (HPV) vaccine and adverse events following immunization with HPV vaccine in Shanghai, 2017-2019. Chin J Vaccines Immunization. 2020;26:322–5+48.
  • Hu S, Xu X, Zhang Y, Liu Y, Yang C, Wang Y, Wang Y, Yu Y, Hong Y, Zhang X, et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: implications for vaccine roll-out in mainland China. Vaccine. 2021;39(1):35–44. doi:10.1016/j.vaccine.2020.11.029.
  • Zhang Y, Wang Y, Liu L, Fan Y, Liu Z, Wang Y, Nie S. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: a meta-analysis of 58 observational studies. BMC Public Health. 2016;16(1):216. doi:10.1186/s12889-016-2873-8.
  • Jongen VW, van der Loeff MFS, Boyd A, Petrignani M, Prins M, van der Wal M, Nielen A, de Melker H, Paulussen TGWM, Alberts CJ, et al. Human papillomavirus vaccination uptake: a longitudinal study showing ethnic differences in the influence of the intention-to-vaccinate among parent-daughter dyads. Hum Vaccin Immunother. 2021;17(4):990–99. doi:10.1080/21645515.2020.1808411.
  • Ng SS, Hutubessy R, Chaiyakunapruk N. Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-valent vaccine, gender-neutral and multiple age cohort vaccination. Vaccine. 2018;36(19):2529–44. doi:10.1016/j.vaccine.2018.03.024.
  • Kim Y, Lee H, Seo JM. Integrated diabetes self-management program using smartphone application: a randomized controlled trial. West J Nurs Res. 2021;44(4):193945921994912. doi:10.1177/0193945921994912.
  • Motahari-Tabari NS, Nasiri-Amiri F, Faramarzi M, Shirvani MA, Bakhtiari A, Omidvar S. The effectiveness of information-motivation-behavioral skills model on self-care practices in early pregnancy to prevent gestational diabetes mellitus in Iranian overweight and obese women: a randomized controlled trial. Int Q Community Health Educ. 2021:272684x211020300. doi:10.1177/0272684X211020300.
  • Bakır E, Çavuşoğlu H, Mengen E. Effects of the information-motivation-behavioral skills model on metabolic control of adolescents with Type 1 diabetes in Turkey: randomized controlled study. J Pediatr Nurs. 2021;58:e19–e27. doi:10.1016/j.pedn.2020.11.019.
  • Liang X, Yang J, Abdullah AS, He Z, Yang L. The evaluation of the effect of ICT in HIV prevention in the general population in China based on an information-motivation-behavioral skill model. Biomed Res Int. 2020;2020:8786467. doi:10.1155/2020/8786467.
  • Fisher JD, Fisher WA, Misovich SJ, Kimble DL, Malloy TE. Changing AIDS risk behavior: effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population. Health Psychol. 1996;15(2):114–23. doi:10.1037/0278-6133.15.2.114.
  • Perez GK, Cruess DG, Strauss NM. A brief information-motivation-behavioral skills intervention to promote human papillomavirus vaccination among college-aged women. Psychol Res Behav Manag. 2016;9:285–96. doi:10.2147/PRBM.S112504.
  • Fisher WA. Understanding human papillomavirus vaccine uptake. Vaccine. 2012;30(Suppl 5):F149–56. doi:10.1016/j.vaccine.2012.04.107.
  • Zhang X, Wang Z, Ren Z, Li Z, Ma W, Gao X, Zhang R, Qiao Y, Li J. HPV vaccine acceptability and willingness-related factors among Chinese adolescents: a nation-wide study. Hum Vaccin Immunother. 2021;17(4):1025–32. doi:10.1080/21645515.2020.1812314.
  • Zhang X, Liu CR, Wang ZZ, Ren ZF, Feng XX, Ma W, Gao X-H, Zhang R, Brown MD, Qiao Y-L, et al. Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents : a multi-center intervention follow-up study. Vaccine. 2020;38(20):3665–70. doi:10.1016/j.vaccine.2020.03.032.
  • Liu CR, Liang H, Zhang X, Pu C, Li Q, Li QL, Ren F-Y, Li J. Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China. BMC Public Health. 2019;19(1):488. doi:10.1186/s12889-019-6823-0.
  • Kester LM, Shedd-Steele RB, Dotson-Roberts CA, Smith J, Zimet GD. The effects of a brief educational intervention on human papillomavirus knowledge and intention to initiate HPV vaccination in 18-26 year old young adults. Gynecol Oncol. 2014;132(Suppl 1):S9–12. doi:10.1016/j.ygyno.2013.12.033.
  • Molokwu J, Dwivedi A, Mallawaarachchi I, Hernandez A, Shokar N. Tiempo de Vacunarte (time to get vaccinated): outcomes of an intervention to improve HPV vaccination rates in a predominantly Hispanic community. Prev Med. 2019;121:115–20. doi:10.1016/j.ypmed.2019.02.004.
  • Fu LY, Bonhomme LA, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: a systematic review. Vaccine. 2014;32(17):1901–20. doi:10.1016/j.vaccine.2014.01.091.
  • Karanth SS, Lairson DR, Savas LS, Vernon SW, Fernandez ME. The cost of developing a computerized tailored interactive multimedia intervention vs. a print based Photonovella intervention for HPV vaccine education. Eval Program Plann. 2017;63:1–6. doi:10.1016/j.evalprogplan.2017.02.009.
  • Gottvall M, Tydén T, Höglund AT, Larsson M. Knowledge of human papillomavirus among high school students can be increased by an educational intervention. Int J STD AIDS. 2010;21(8):558–62. doi:10.1258/ijsa.2010.010063.
  • Pitts MK, Dyson SJ, Rosenthal DA, Garland SM. Knowledge and awareness of human papillomavirus (HPV): attitudes towards HPV vaccination among a representative sample of women in Victoria, Australia. Sex Health. 2007;4(3):177–80. doi:10.1071/SH07023.
  • Thanasas I, Lavranos G, Gkogkou P, Paraskevis D. The effect of health education on adolescents’ awareness of HPV infections and attitudes towards HPV vaccination in Greece. Int J Environ Res Public Health. 2022;19(1):503. doi:10.3390/ijerph19010503.
  • Liu Y, Di N, Tao X. Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China. Hum Vaccin Immunother. 2020;16(1):116–23. doi:10.1080/21645515.2019.1638727.
  • Deng C, Chen X, Liu Y. Human papillomavirus vaccination: coverage rate, knowledge, acceptance, and associated factors in college students in mainland China. Hum Vaccin Immunother. 2021;17:828–35.
  • You D, Han L, Li L, Hu J, Zimet GD, Alias H, Danaee M, Cai L, Zeng F, Wong LP, et al. Human Papillomavirus (HPV) vaccine uptake and the willingness to receive the HPV vaccination among female college students in China: a multicenter study. Vaccines (Basel). 2020;8(1). doi:10.3390/vaccines8010031.
  • Mascaro V, Pileggi C, Currà A, Bianco A, Pavia M. HPV vaccination coverage and willingness to be vaccinated among 18–30 year-old students in Italy. Vaccine. 2019;37(25):3310–16. doi:10.1016/j.vaccine.2019.04.081.
  • Organization WH. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2021.
  • Ogundele OA, Omotoso AA, Fagbemi AT. COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria. Hum Vaccin Immunother. 2021;17(3):661–63. doi:10.1080/21645515.2020.1815490.
  • Ota MOC, Badur S, Romano-Mazzotti L, Friedland LR. Impact of COVID-19 pandemic on routine immunization. Ann Med. 2021;53(1):2286–97. doi:10.1080/07853890.2021.2009128.
  • Aizawa Y, Katsuta T, Sakiyama H, Tanaka-Taya K, Moriuchi H, Saitoh A. Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan. Vaccine. 2021;39(29):4006–12. doi:10.1016/j.vaccine.2021.05.050.
  • Piché-Renaud PP, Ji C, Farrar DS, Friedman JN, Science M, Kitai I, Burey S, Feldman M, Morris SK. Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada. Vaccine. 2021;39(31):4373–82. doi:10.1016/j.vaccine.2021.05.094.
  • Fei C, Jun L, Yuli L. Chinese expert consensus on comprehensive management in the three-level prevention and control of cervical cancer in prevention and control of COVID-19 pandemi. Chin J Pract Gynecol Obstetrics. 2021;37:185–88.
  • Wong LP, Han L, Li H, Zhao J, Zhao Q, Zimet GD. Current issues facing the introduction of human papillomavirus vaccine in China and future prospects. Hum Vaccin Immunother. 2019;15(7–8):1533–40. doi:10.1080/21645515.2019.1611157.
  • Zhao F, Qiao Y. Cervical cancer prevention in China: a key to cancer control. Lancet. 2019;393(10175):969–70. doi:10.1016/S0140-6736(18)32849-6.
  • Patel DA, Zochowski M, Peterman S, Dempsey AF, Ernst S, Dalton VK. Human papillomavirus vaccine intent and uptake among female college students. J Am Coll Health. 2012;60(2):151–61. doi:10.1080/07448481.2011.580028.
  • Lenehan JG, Leonard KC, Nandra S, Isaacs CR, Mathew A, Fisher WA. Women’s knowledge, attitudes, and intentions concerning Human Papillomavirus vaccination: findings of a waiting room survey of obstetrics-gynaecology outpatients. J Obstet Gynaecol Can. 2008;30(6):489–99. doi:10.1016/S1701-2163(16)32864-X.
  • Giede C, McFadden LL, Komonoski P, Agrawal A, Stauffer A, Pierson R. The acceptability of HPV vaccination among women attending the University of Saskatchewan Student Health Services. J Obstet Gynaecol Can. 2010;32(7):679–86. doi:10.1016/S1701-2163(16)34572-8.
  • Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health. 2010;10(1):27. doi:10.1186/1472-6874-10-27.
  • Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. Bmj. 2008;336(7652):1056–58. doi:10.1136/bmj.39541.534109.BE.
  • Allen JD, Mohllajee AP, Shelton RC, Othus MK, Fontenot HB, Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med. 2009;48(5):420–25. doi:10.1016/j.ypmed.2008.12.005.
  • Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475–80. doi:10.1016/j.socscimed.2009.05.024.
  • Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz L, Smith JS. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197–204. doi:10.1097/OLQ.0b013e3181f12dbf.
  • Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol. 2008;111(5):1103–10. doi:10.1097/AOG.0b013e31817051fa.
  • DiClemente RJ, Murray CC, Graham T, Still J. Overcoming barriers to HPV vaccination: a randomized clinical trial of a culturally-tailored, media intervention among African American girls. Hum Vaccin Immunother. 2015;11(12):2883–94. doi:10.1080/21645515.2015.1070996.
  • Krawczyk AL, Perez S, Lau E, Holcroft CA, Amsel R, Knauper B, Rosberger Z. Human papillomavirus vaccination intentions and uptake in college women. Health Psychol. 2012;31(5):685–93. doi:10.1037/a0027012.
  • Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, Del Carmen MG. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2187–98. doi:10.1158/1055-9965.EPI-10-0217.
  • Rhodes SD, Diclemente RJ. Psychosocial predictors of hepatitis B vaccination among young African-American gay men in the deep south. Sex Transm Dis. 2003;30(5):449–54. doi:10.1097/00007435-200305000-00013.
  • Guidry JPD, Laestadius LI, Vraga EK, Miller CA, Perrin PB, Burton CW, Ryan M, Fuemmeler BF, Carlyle KE. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am J Infect Control. 2021;49(2):137–42. doi:10.1016/j.ajic.2020.11.018.
  • Gerend MA, Shepherd JE. Predicting human papillomavirus vaccine uptake in young adult women: comparing the health belief model and theory of planned behavior. Ann Behav Med. 2012;44(2):171–80. doi:10.1007/s12160-012-9366-5.